By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Enterprise Replace Reaches Settlement with European Medicines Company on Second Confirmatory Trial for HyBryte On April 3, 2024, Soligenix, Inc. (NASDAQ:SNGX) introduced it has reached settlement with the European Medicines Company (EMA) on the important thing design parts for a confirmatory Part 3 trial … Read more
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace Replace on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is growing IMNN-101, which is a COVID-19 seasonal vaccine booster based mostly on the corporate’s PlaCCine know-how. It’s a DNA vaccine that addresses plenty of limitations of present vaccines, together with the sturdiness of antigen expression, … Read more
When studying about investing, you typically hear that it’s necessary to do your analysis. That educated investing is the important thing to profitable investing. That you must by no means make investments a dime till you perceive simply what it’s you’re investing in. Nonetheless, there’s not a lot data on the market about the place … Read more
By David Bautz, PhD NASDAQ:CRVO READ THE FULL CRVO RESEARCH REPORT Enterprise Replace Biomarker Knowledge Introduced at AD/PD 2024 On March 5, 2024, CervoMed Inc. (NASDAQ:CRVO) introduced the presentation of biomarker knowledge from the AscenD-LB Part 2a trial of neflamapimod in sufferers with dementia with Lewy our bodies (DLB) was featured in a poster presentation … Read more
1. Name for Papers: Oxford Workshop in Honour of Decide Theodor Meron . The Oxford College College of Legislation, All Souls School, and Trinity School will host a workshop on 21 June 2024 in honour of Decide Theodor Meron, Visiting Professor of Worldwide Legislation on the College of Oxford and Honorary Fellow of Trinity School, … Read more
